Ghodsi, A., Demirci, R. A., Gulati, R., Nelson, P., Raychaudhuri, R., Cheng, H. H., Sunkara, R., Khan, H. M., Nadal, R., Hsieh, A. C., Grivas, P., Montgomery, R. B., Yezefski, T., Yu, E. Y., Schweizer, M. T., Chen, D. L., Iravani, A. I. (2026). Feasibility and outcomes of response-adapted and retreatment
                    <sup>177</sup>
                    Lu-PSMA-617 therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.184